Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

235 та иш

Иш: Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

    F. Stephen Hodi, Steven O’Day, David F. McDermott +26

    Мақола20109 иқтибос
    ABI

  2. Cancer Statistics, 2021

    Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs +1

    Мақола20217 иқтибос
    ABI

  3. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer

    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6

    Шарҳ мақола20216 иқтибос
    ABI

  4. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

    Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda +27

    Мақола20135 иқтибос
    ABI

  5. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Мақола20215 иқтибос
    ABI

  6. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

    Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7

    Шарҳ мақола20195 иқтибос
    ABI

  7. EP4 receptor as a novel promising therapeutic target in colon cancer

    Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5

    Шарҳ мақола20205 иқтибос
    ABI

  8. The role of Th17 cells in the pathogenesis and treatment of breast cancer

    Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5

    Шарҳ мақола20225 иқтибос
    ABI

  9. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

    Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11

    Мақола20245 иқтибос
    ABI

  10. Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

    Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11

    Мақола20224 иқтибос
    ABI

  11. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    Мақола20234 иқтибос
    ABI

  12. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

    Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo +13

    Мақола20064 иқтибос
    ABI

  13. RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

    Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11

    Мақола20214 иқтибос
    ABI

  14. Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

    Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4

    Шарҳ мақола20234 иқтибос
    ABI

  15. CTLA-4 and PD-1 Pathways

    Elizabeth I. Buchbinder, Anupam M. Desai

    Шарҳ мақола20153 иқтибос
    ABI

  16. Role of the Microbiota in Immunity and Inflammation

    Yasmine Belkaid, Timothy W. Hand

    Шарҳ мақола20143 иқтибос
    ABI

  17. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer

    Dariusz Waniczek, Zbigniew Lorenc, Mirosław Śnietura +3

    Мақола20173 иқтибос
    ABI

  18. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

    Andrea Nicolini, Paola Ferrari

    Шарҳ мақола20243 иқтибос
    ABI

  19. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges

    Frans V. Suurs, Marjolijn N. Lub–de Hooge, Elisabeth G.E. de Vries +1

    Шарҳ мақола20192 иқтибос
    ABI

  20. VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

    Magali Terme, Simon Pernot, Elie Marcheteau +7

    Мақола20122 иқтибос
    ABI

  21. Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

    Peter Attia, Ajay V. Maker, Leah Haworth +2

    Мақола20052 иқтибос
    ABI

  22. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

    Gabriela Bindea, Bernhard Mlecnik, Marie Tosolini +14

    Мақола20132 иқтибос
    ABI

  23. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

    Nicolás J. Llosa, Michael Cruise, Ada Tam +15

    Мақола20142 иқтибос
    ABI

  24. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

    David G. DeNardo, Lisa M. Coussens

    Шарҳ мақола20072 иқтибос
    ABI

  25. Microenvironmental regulation of metastasis

    Johanna A. Joyce, Jeffrey W. Pollard

    Шарҳ мақола20082 иқтибос
    ABI